TD Cowen had upgraded Merck in early 2024 based on confidence in Keytruda and Gardasil’s performance, a lack of binary risks, and an attractive valuation. However, setbacks in Gardasil’s China ...

Investing.com -- TD Cowen downgraded Merck & Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of ...

Investing.com -- TD Cowen downgraded Merck &Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of ...

TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with Gardasil’s challenges in China. It is ...

TD Cowen initiated coverage of Repligen (RGEN) with a Buy rating and $200 price target Repligen is well positioned for “industry-leading” growth and margin expansion as it is over-indexed ...

We recently compiled a list of the 11 AI News and Ratings You Shouldn't Miss. In this article, we are going to take a look at where Arm Holdings plc (NASDAQ:ARM) stands against the other AI stocks ...

On February 6, TD Cowen analyst Krish Sankar maintained a Buy rating on ARM Holdings with a $200 price target, due to strong growth potential. The company exceeded December quarter revenue ...

Investing.com - U.S. President Donald Trump's decision to order the Treasury to cease production of the penny would likely survive judicial review, according to analysts at TD Cowen. On Sunday ...

On Monday, TD Cowen's analysts adjusted their outlook on Neste Oyj (NESTE:FH) (OTC: NTOIY), reducing the price target from €19.00 to €15.00 while maintaining a Hold rating on the stock. The stock, ...

We recently compiled a list of the 11 AI News and Ratings You Shouldn't Miss. In this article, we are going to take a look at where Arm Holdings plc (NASDAQ:ARM) stands against the other AI stocks.